| 2024-11-25 |
详情>>
内部人交易：
Pomerantz Roger等共交易2笔
|
| 2024-11-13 |
详情>>
股本变动：
变动后总股本3974.42万股
变动原因 ▼▲
- 原因：
- From June 30, 2024 to September 30, 2024
Issuance of common stock upon vesting of restricted stock units
Conversion of convertible preferred stock into common stock
|
| 2024-11-13 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.75美元,归母净利润-2952.4万美元,同比去年增长20.83%
|
| 2024-08-14 |
详情>>
业绩披露：
2024年中报每股收益-0.48美元,归母净利润-1897.1万美元,同比去年增长23.17%
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益-0.23美元,归母净利润-914.1万美元,同比去年增长25.13%
|
| 2024-04-26 |
股东大会：
将于2024-06-18召开股东大会
会议内容 ▼▲
- 1.To elect four (4) Class III directors to hold office until our 2027 annual meeting of stockholders and until their respective successors are elected and qualified.
2.To approve, on an advisory basis, the compensation of our named executive officers.
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024.
4.To transact other business that may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2024-03-07 |
详情>>
业绩披露：
2023年年报每股收益-1.32美元,归母净利润-5105.8万美元,同比去年增长-3.78%
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.97美元,归母净利润-3729.3万美元,同比去年增长4.06%
|
| 2023-08-14 |
详情>>
业绩披露：
2023年中报每股收益-0.64美元,归母净利润-2469.3万美元,同比去年增长-16.87%
|
| 2023-05-09 |
详情>>
业绩披露：
2023年一季报每股收益-0.32美元,归母净利润-1220.9万美元,同比去年增长-15.77%
|
| 2023-04-27 |
股东大会：
将于2023-06-08召开股东大会
会议内容 ▼▲
- 1.To elect three (3) Class II directors to hold office until our 2026 annual meeting of stockholders and until their respective successors are elected and qualified.
2.To approve, on an advisory basis, the compensation of our named executive officers.
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2023.
4.To transact other business that may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2023-03-14 |
详情>>
业绩披露：
2022年年报每股收益-1.3美元,归母净利润-4919.7万美元,同比去年增长57.13%
|
| 2022-11-10 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-1.03美元,归母净利润-3887.1万美元,同比去年增长62.38%
|
| 2022-08-09 |
详情>>
业绩披露：
2022年中报每股收益-0.56美元,归母净利润-2112.8万美元,同比去年增长76.10%
|
| 2022-04-27 |
股东大会：
将于2022-06-08召开股东大会
会议内容 ▼▲
- 1.To elect three (3) Class I directors to hold office until our 2025 annual meeting of stockholders and until their respective successors are elected and qualified.
2.To approve, on an advisory basis, the compensation of our named executive officers.
3.To approve the 2022 Employee Stock Purchase Plan.
4.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022.
5.To transact other business that may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2021-12-14 |
复牌提示：
2021-12-13 11:30:36 停牌，复牌日期 2021-12-13 11:35:36
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-02-24 |
详情>>
拆分方案：
每3.5000合并分成1.0000股
|
| 2021-01-14 |
股东大会：
将于2021-02-22召开股东大会
会议内容 ▼▲
- 1.Approve an amendment to the amended and restated certificate of incorporation of Sunesis to effect a reverse stock split of Sunesis Common Stock at a ratio within the range between 3-for-1 and 6-for-1 (with such ratio to be mutually agreed upon by Sunesis and Viracta prior to the effectiveness of the Merger);
2.Approve (i) the issuance of shares of Sunesis capital stock pursuant to the Merger, which will represent more than 20% of the shares of Sunesis Common Stock outstanding immediately prior to the Merger, and (ii) the change of control resulting from the Merger, pursuant to Nasdaq Listing Rules 5635(a) and 5635(b), respectively;
3.Approve the Sunesis 2021 Equity Incentive Plan, a form of which is attached as Annex E to this proxy statement/prospectus/information statement;
4.Approve, on non-binding advisory basis, the compensation that will or may become payable by Sunesis to its named executive officers in connection with the merger (the “Executive Merger Compensation Proposal”);
5.Approve a postponement or adjournment of the Sunesis virtual special meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal Nos. 1, 2, 3 or 4.
|
| 2020-09-03 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2020-04-28 |
股东大会：
将于2020-06-16召开股东大会
会议内容 ▼▲
- 1.To elect two directors nominated by the board of directors of the Company, or the Board, to serve until the 2023 annual meeting of stockholders, as described in this proxy statement.
2.To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in this proxy statement.
3.To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation, to effect a reverse stock split of the Company’s common stock pursuant to which any whole number of outstanding shares between and including 2 and 12 shares would be combined, converted and changed into one share of common stock, with the final exchange ratio to be determined by the Board in its discretion.
4.To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2020.
5.To transact any other business that may properly come before the Annual Meeting or any adjournment or postponement thereof, by or at the direction of the Board.
|
| 2019-04-12 |
股东大会：
将于2019-06-06召开股东大会
会议内容 ▼▲
- 1.To elect three directors nominated by the board of directors to serve until the 2022 annual meeting of stockholders, as described in this proxy statement.
2.To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in this proxy statement.
3.To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers.
4.To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2019.
5.To transact any other business that may properly come before the Annual Meeting or any adjournment or postponement thereof, by or at the direction of the board of directors.
|
| 2018-04-25 |
股东大会：
将于2018-06-06召开股东大会
会议内容 ▼▲
- 1.To elect two directors nominated by the board of directors to serve until the 2021 annual meeting of stockholders, as described in this proxy statement.
2.To approve, on an advisory basis, the compensation of the Sunesis named executive officers, as disclosed in this proxy statement.
3.To ratify the filing and effectiveness of the certificate of amendment to our amended and restated certificate of incorporation filed with the Secretary of State of the State of Delaware on September 7, 2016 (the “Certificate of Amendment”) and the one for six reverse stock split of our common stock (the “2016 Reverse Stock Split”) that was effected thereby (the “Amendment Ratification”).
4.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of Sunesis for the year ending December 31, 2018.
5.To transact any other business that may properly come before the 2018 Annual Meeting or any adjournment or postponement thereof, by or at the direction of the Board of Directors.
|
| 2017-04-20 |
股东大会：
将于2017-05-31召开股东大会
会议内容 ▼▲
- 1.To elect two directors nominated by the board of directors to serve until the 2020 annual meeting of stockholders, as described in this proxy statement.
2.To approve, on an advisory basis, the compensation of the Sunesis named executive officers, as disclosed in this proxy statement.
3.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of Sunesis for the year ending December 31, 2017.
4.To approve the stock option exchange program, as described in this proxy statement.
5.To approve the amendment of the Sunesis 2011 Equity Incentive Plan, as described in this proxy statement.
6.To transact any other business that may properly come before the annual meeting or any adjournment or postponement thereof.
|
| 2016-09-07 |
详情>>
拆分方案：
每6.0000合并分成1.0000股
|
| 2016-04-25 |
股东大会：
将于2016-06-07召开股东大会
会议内容 ▼▲
- 1.To elect three directors nominated by the board of directors to serve until the 2019 annual meeting of stockholders, as described in this proxy statement.
2.To approve, on an advisory basis, the compensation of the Sunesis named executive officers, as disclosed in this proxy statement.
3.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of Sunesis for the year ending December 31, 2016.
4.To approve an amendment to Sunesis’ amended and restated certificate of incorporation in order to effect a reverse stock split of the issued and outstanding shares of Sunesis’ common stock.
5.To transact any other business that may properly come before the annual meeting or any adjournment or postponement thereof.
|